Answers are grounded in this paper and cite their sources.
Liver diseases are a severe global health challenge. Liver transplantation, as the gold-standard therapy for end stage liver disease, still suffers the fundamental constraint of severe donor shortage. 3D bioprinting technology provides new opportunities to construct functional liver organ model. Metabolic zonation is the core organizational principle of liver function, which is driven by gradients of oxygen and signaling molecules formed during the blood flow from the portal tract to the central vein. The existing in vitro model can not recapitulate this spatial heterogeneity, which severely limits the accuracy of drug metabolism research and toxicity prediction. In this article, the capability boundaries of four mainstream bioprinting technologies, i.e. extrusion-based, DLP photocuring, coaxial printing and embedded sacrificial material printing in reconstructing metabolic zonation are systematically reviewed. On this basis, the multi-technology collaborative strategy is proposed which starts from the target metabolic zonation map and works backward to match the technologies, and the three-layer architecture framework span from microscale topology to macroscale perfusion is constructed. This strategy provides the theoretic reference for advancing 3D bioprinted liver models from morphological biomimicry towards functional biomimicry. The future research may further verify the real efficacy of this framework in reproducing zone-dependent metabolism in in vitro pharmacological screening, and to explore the standardized application pathway in high-throughput system.
No takes yet. Share an insight, caveat, or question.
Zhexin Jin (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: